BackIronwood Pharmaceuticals Overview
Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A

Ironwood Pharmaceuticals Target Price

Ironwood Pharmaceuticals target price — quarterly history, peer benchmarks, and growth trends.

Get informed when a big investor buys or sells

+ Follow

Share Price

$4.36

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-02-26JefferiesAmy Li$3.715.1% downsideOpen
2026-01-05Craig-Hallum$5.730.7% upsideOpen
2026-01-04Wells Fargo$514.7% upsideOpen
2025-11-26Craig-Hallum$3.812.8% downsideOpen
2025-04-14Leerink PartnersFaisal Khurshid$177.1% downsideOpen
2025-01-31Wells FargoMohit Bansal$760.6% upsideOpen
2024-09-09Leerink PartnersFaisal Khurshid$514.7% upsideOpen
2024-08-09Wells FargoMohit Bansal$12175.2% upsideOpen
2024-05-22Piper SandlerDavid Amsellem$18312.8% upsideOpen
2024-05-22Wells FargoMohit Bansal$14221.1% upsideOpen
2022-04-22Piper SandlerDavid Amsellem$16267% upsideOpen

Ironwood Pharmaceuticals (IRWD) FAQ

Stockcircle tracks target price for Ironwood Pharmaceuticals (IRWD), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Ironwood Pharmaceuticals's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main IRWD overview so you can move from this figure to the surrounding analysis quickly.